SEC Company Response from Tiziana Life Sciences Ltd (TLSA) (CIK 0001723069) (TLSA) — Mar 1, 2022
Tiziana Life Sciences Ltd (TLSA) (CIK 0001723069)
Date: March 1, 2022 · CIK: 0001723069 · Accession: 0001213900-22-010018
AI Filing Summary & Sentiment
File numbers found in text: 333-252441
Show Raw Text
CORRESP
1
filename1.htm
Tiziana Life Sciences Ltd.
55 Park Lane
London
W1k 1NA
March 1, 2022
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Alan Campbell
Re:
Tiziana Life Sciences Ltd.
Amendment No. 1 to Form F-3 Registration Statement
Filed February 25, 2022
File No. 333-252441
Ladies and Gentlemen:
Pursuant to Rule 461 of the
General Rules and Regulations under the Securities Act of 1933, as amended, Tiziana Life Sciences Ltd. (the “Company”)
respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective
at 4:00 p.m., Eastern Standard Time, on Thursday, March 3, 2022, or as soon thereafter as possible.
Please notify Jeffrey Fessler
of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the Registration
Statement has been declared effective pursuant to this acceleration request.
TIZIANA LIFE SCIENCES LTD.
By:
/s/ Kunwar Shailubhai
Name:
Kunwar Shailubhai
Title:
Chief Executive Officer